Meeting Designed For:

Join professionals interested in a comprehensive overview of the current biopharma pharmaceutical, medical device, and/or diagnostics landscape in Canada:

• Pharmacovigilance and Drug Safety
• Risk Management
• Clinical Research, Management, and Operations
• Regulatory Affairs and Operations
• Medical Affairs and Scientific Communication
• Quality Assurance
• Life Sciences R&D
• Project Management
• Real-World Data and Real-World Evidence
• Data Management

Upon completion, learners should be able to:

• Identify Health Canada's Precision Regulating Initiatives and amendments to the Food and Drugs Act to ensure precise regulatory solutions
• Discuss Health Canada's international collaboration initiatives and their impact on regulatory processes and clinical trials
• Determine the unique advantages and challenges of conducting clinical trials in Canada and how it positions itself as a global leader
• Develop strategies to enhance equity, diversity, inclusion, and accessibility in clinical trials, focusing on underrepresented groups
• Evaluate the latest developments in pharmacovigilance, including Health Canada's guidance on adverse drug reaction reporting and post-market surveillance
• Examine the role of artificial intelligence in regulatory processes, clinical development, and pharmacovigilance, and understand the implications for the industry
• Evaluate pathways for drug development and patient access in the rare diseases sector, focusing on regulatory strategies and collaboration opportunities
• Identify decentralized clinical trials, electronic patient medication information, and innovative approaches in clinical trial operations
• Discuss the importance of transparency in regulatory submissions and the role of data anonymization in protecting personal and confidential business information